Vienna Challenge Chamber

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Journal of Allergy and Clinical Immunology · 2009 · 174 citations

Asthma, Allergy, Early Onset +9

A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy

Aline Zimmer, Julien Bouley, Maxime Le Mignon et al. · Journal of Allergy and Clinical Immunology · 2012 · 164 citations

Clinical Immunology, Allergen-specific Sublingual Immunotherapy, Allergy +12

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Hendrik Nolte, Jennifer Maloney, Harold S. Nelson et al. · Journal of Allergy and Clinical Immunology · 2015 · 158 citations

Environmental Allergy, House Dust, Allergy +13

Mass spectrometric analysis for nuclear safeguards

Sergei F. Boulyga, Stefanie Konegger-Kappel, Stephan Richter et al. · Journal of Analytical Atomic Spectrometry · 2015 · 139 citations

Engineering, Atomic Emission Spectroscopy, Measurement +23

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

Petra Zieglmayer, Margarete Focke‐Tejkl, René Schmutz et al. · EBioMedicine · 2016 · 136 citations · Full text